Klonopin Related Published Studies
Well-designed clinical trials related to Klonopin (Clonazepam)
Defense style changes with the addition of psychodynamic group therapy to clonazepam in social anxiety disorder. [2009.07]
Clonazepam quantification in human plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry in a bioequivalence study. [2007.01]
Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder. [2004.09]
A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder. [2004.07]
Topical clonazepam in stomatodynia: a randomised placebo-controlled study. [2004.03]
Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis. [2004.03]
Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder. [2004.02]
Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. [2003.09]
A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder. [2003.01]
Comparative single-dose pharmacokinetics of clonazepam following intravenous, intramuscular and oral administration to healthy volunteers. [2003]
Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression? [2002.08]
The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patient education and self-care for the treatment of jaw pain upon awakening: a randomized clinical trial. [2002.01]
Early coadministration of clonazepam with sertraline for panic disorder. [2001.07]
Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam. [2001.04]
Double-blind clonazepam vs placebo in panic disorder treatment. [2000.12]
Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression. [2000.12]
Comparative bioavailability study of clonazepam after oral administration of two tablet formulations. [2000.10]
A comparison of the efficacy of clonazepam and cognitive-behavioral group therapy for the treatment of social phobia. [2000.07]
Double-blind acute clonazepam vs. placebo in carbon dioxide-induced panic attacks. [2000.05.15]
Reduction of epileptiform activity in response to low-dose clonazepam in children with epilepsy: a randomized double-blind study. [2000.03]
Clonazepam and sertraline: absence of drug interaction in a multiple-dose study. [2000.02]
Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages. [1999.09]
Carbon dioxide induced panic attacks and short term clonazepam treatment. Preliminary study. [1999.06]
Clonazepam treatment of panic disorder in patients with recurrent chest pain and normal coronary arteries. [1999]
Discontinuation of clonazepam in the treatment of social phobia. [1998.10]
Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study. [1998.10]
Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group. [1997.10]
The effects of clonazepam on quality of life and work productivity in panic disorder. [1997.08]
The effectiveness of clonazepam on the Rolandic discharges. [1997.06]
Comparison of cognitive-behavioral therapy and clonazepam for treating periodic limb movement disorder. [1996.06]
Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. [1996.02]
The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma. [1994.08]
A double-blind comparison of clonazepam and placebo in the treatment of neuroleptic-induced akathisia. [1994.06]
Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response. [1994.04]
Clonazepam in childhood anxiety disorders. [1994.03]
Treatment of social phobia with clonazepam and placebo. [1993.12]
A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms. [1993.11]
Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder. [1993.08]
Phenobarbital versus clonazepam for sedative-hypnotic taper in chronic pain patients. A pilot study. [1993.06]
Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder. [1992.12]
Fluoxetine impairs clearance of alprazolam but not of clonazepam. [1992.11]
Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study. [1992.09]
Clonazepam in acute mania: a double blind trial. [1991.06]
Administration of clonazepam in the treatment of TMD and associated myofascial pain: a double-blind pilot study. [1991.06]
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. [1991.02]
Effects of the anticonvulsant benzodiazepine clonazepam on event-related brain potentials in humans. [1991.02]
Double-blind comparison of the effects of clonazepam and lorazepam in acute mania. [1990.12]
Clonazepam in the treatment of social phobia: a pilot study. [1990.05]
Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy. [1990.04]
Clonazepam vs. neuroleptics as adjuncts to lithium maintenance. [1990]
Successful clonazepam treatment of neuroleptic-induced akathisia in older adolescents and young adults: a double-blind, placebo-controlled study. [1989.12]
Effects of clobazam and clonazepam on saccadic eye movements and other parameters of psychomotor performance. [1989]
Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial. [1987.10]
Well-designed clinical trials possibly related to Klonopin (Clonazepam)
Benzodiazepines and GABAergics in treating severe disabling tinnitus of predominantly cochlear origin. [2006]
Effects of group experiential cognitive therapy for the treatment of panic disorder with agoraphobia. [2005.08]
Changes in anxiety sensitivity with pharmacotherapy for panic disorder. [2004.09]
Naltrexone treatment of tardive dyskinesia in patients with schizophrenia. [2004.08]
Assessment of single-dose benzodiazepines on insulin secretion, insulin sensitivity and glucose effectiveness in healthy volunteers: a double-blind, placebo-controlled, randomized cross-over trial [ISRCTN08745124]. [2004.03.04]
Second-line anticonvulsant treatment of neonatal seizures: a video-EEG monitoring study. [2004.02.10]
Correlates of therapeutic response in panic disorder presenting with palpitations: heart rate variability, sleep, and placebo effect. [2003.07]
Therapeutic response to benzodiazepine in panic disorder subtypes. [2003.03.05]
Carbon dioxide test as an additional clinical measure of treatment response in panic disorder. [2002.06]
[May results from randomized clinical trials be generalized? An example from psychopharmacology] [1998.07.20]
Validation of the Bech-Rafaelsen Mania Scale using latent structure analysis. [1997.11]
Generalisability of results from randomised drug trials. A trial on antimanic treatment. [1997.03]
[High dose ifosfamide at 15 g/m2/cycle: a feasibility study in 10 patients] [1997.02]
Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. [1996.03]
Anticonvulsant drugs for management of pain: a systematic review. [1995.10.21]
Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. [1993.10]
Treatment of spasticity in children with low dose benzodiazepine. [1993.07]
Effectiveness of piracetam in cortical myoclonus. [1993]
A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation. [1990]
Pharmacological study in Meige's syndrome with predominant blepharospasm. [1988.02]
Other research related to Klonopin (Clonazepam)
Clonazepam withdrawal-induced catatonia. [2009.05]
Clonazepam as a therapeutic adjunct to improve the management of depression: a brief review. [2009.04]
Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002-2007. [2009.01.30]
A pilot study of clonazepam versus psychodynamic group therapy plus clonazepam in the treatment of generalized social anxiety disorder. [2008.12]
Clonazepam oral droplets for the treatment of acute epileptic seizures. [2008.12]
Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni. [2008.12]
[Comparison of metoprolol vs clonazepam as a first treatment choice among patients with neurocardiogenic syncope] [2008.11]
A pilot study of clonazepam versus psychodynamic group therapy plus clonazepam in the treatment of generalized social anxiety disorder. [2008.09.05]
Clonazepam for chemotherapy-induced nausea and vomiting (CINV). [2008.07]
Bioequivalence of two commercial preparations of escitalopram oxalate/clonazepam using a liquid chromatography-electrospray mass spectrometry method. [2008]
Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam. [2007.12]
Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma. [2007.09]
Neonatal withdrawal syndrome following in utero exposure to paroxetine, clonazepam and olanzapine. [2007.08]
Oxidative stress parameters in diabetic rats submitted to forced swimming test: the clonazepam effect. [2007.06.18]
A case of major form familial hyperekplexia: prenatal diagnosis and effective treatment with clonazepam. [2007.06]
Clonazepam treatment of pathologic childhood aerophagia with psychological stresses. [2007.04]
Multi-drug overdose risperidone, ziprasidone, valproate, trihexyphenidyl, and clonazepam. [2007.02]
Possible predictors of response to clonazepam augmentation therapy in patients with protracted depression. [2007.01]
Characterization of the anticonvulsant, behavioral and pharmacokinetic interaction profiles of stiripentol in combination with clonazepam, ethosuximide, phenobarbital, and valproate using isobolographic analysis. [2006.11]
7-Nitroindazole enhances dose-dependently the anticonvulsant activities of conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. [2006.09]
Effect of tubing on loss of clonazepam administered by continuous subcutaneous infusion. [2006.06]
Clonazepam in the treatment of psychiatric disorders: an update. [2006.05]
Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting. [2006.03]
Misleading effects of clonazepam in symptomatic electrical status epilepticus during sleep syndrome. [2006.02]
[Misuse of clonazepam (Rivotril): recent trends] [2006.01]
A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam. [2005.11.15]
Clonazepam pharmacokinetics: comparison of subcutaneous microsphere injection with multiple-dose oral administration. [2005.11]
Pulsatile tinnitus: treatment with clonazepam and propranolol. [2005.01]
|
